ChronoScale signs agreements bringing total contracted run-rate revenue to $1B; sells Ekso Bionics to Wandercraft in signed-and-closed deal

ChronoScale Holdings Corporation announced agreements bringing total company contracted run-rate revenue to $1 billion, and the sale of its Ekso Bionics business unit to Wandercraft in a simultaneously signed and closed deal approved unanimously by both boards.

Detected & updated continuously · Source: Nebula